Warning Letter — npouches.com
The FDA issued a warning letter to npouches.com via the Center for Tobacco Products regarding regulatory violations discovered through an investigation of their commercial activities.
This action primarily affects npouches.com, and by extension, other online retailers or distributors of tobacco and nicotine products under the jurisdiction of the Center for Tobacco Products.
The issuance of a Warning Letter from the Center for Tobacco Products indicates that the FDA has identified significant regulatory non-compliance, likely involving the sale or distribution of unauthorized tobacco products. This suggests a continued enforcement priority regarding digital marketplaces and nicotine delivery systems that have not received necessary marketing authorizations. Regulatory teams should interpret this as a signal that online retail presence does not exempt entities from federal oversight regarding product authorization and labeling requirements.
Review digital storefronts and marketing materials for compliance with the Federal Food, Drug, and Cosmetic Act; immediately audit product listings for unauthorized nicotine delivery systems; monitor for post-market enforcement actions from the Center for Tobacco Products regarding non-compliant inventory.
FDA Warning Letter issued to: npouches.com. 05/19/2026 — Center for Tobacco Products. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/npouchescom-730125-05192026
Open in openFDA / FDA.gov